Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:

NCT ID: NCT03230383 Completed - Healthy Subjects Clinical Trials

A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects

Start date: August 1, 2017
Phase: Phase 1
Study type: Interventional

This will be an investigator- and subject-blinded (sponsor open), randomized, placebo controlled, sequential, ascending, multiple oral dose study, with 5 planned cohorts (optional sixth and seventh cohorts). A total of approximately 50 (if 5 cohorts), 60 (if 6 cohorts), and up to 70 (if 7 cohorts) subjects will be randomized in this study. Subjects in each cohort will be randomized to receive PF-06865571 or matching placebo with approximately 10 subjects dosed in each cohort. For a given subject in any cohort, the total study duration from screening to follow-up phone call will be between approximately 7 to 11 weeks.

NCT ID: NCT03227276 Completed - Clinical trials for Overweight and Obesity

Efficacy and Safety of Litramine in 1 Year Weight Loss Study

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

To evaluate the efficacy of Litramine in reducing body weight in the context of an energy-restricted diet in overweight and moderately obese subjects

NCT ID: NCT03223935 Completed - Overweight Clinical Trials

Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia

Start date: August 11, 2017
Phase: N/A
Study type: Interventional

An investigation on the effects of roasted pulse snacks on post-prandial glycemic and satiety response in healthy young adults.

NCT ID: NCT03223649 Completed - Healthy Clinical Trials

Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth

Start date: July 26, 2017
Phase: Phase 2
Study type: Interventional

Background: Some studies have found that people can better process sugars when they take walking breaks. Studies have also found that children's attention and memory may improve after exercise. It is not known if short walking breaks have the same effects. Researchers want to study if breaking up sitting with walking for 6 days helps children s bodies use sugars and improves concentration. Objectives: To learn if breaking up sedentary (low-activity) time with short walking breaks over 6 days affects how children s bodies use sugar. To learn if breaking up sedentary time changes children s attention, memory, feelings, activity, or eating. Eligibility: Children ages 7-11 in general good health Design: Participants will be screened with: - Medical history - Physical exam - Fasting blood tests. On 2 out of 7 total study visits, participants cannot eat or drink after 10 p.m. the night before. - Full-body X-ray - EKG (Electronic signals that record heart function through stickers) - Treadmill exercise. Heart, blood pressure, and oxygen will be monitored. - Questions about the child s health, socialization, and activity, and parent s education and economic status - Picture vocabulary test - Dietician meeting (Questions about eating habits) Participants will have visits on 6 consecutive days. Over that time, they will wear 2 devices to monitor blood sugar and activity (even while at home). Participants will have 5 after-school visits. These include: - Health check - Snack plus food for the next 24 hours - Activity monitored - 3-hour sitting tests. Participants will do non-active things. Some will have 3-minute walks every 30 minutes. - Cognitive tests and questions about mood and anxiety are given on days #1 & 5. Participants will fast before the last visit in the morning. They will have: - 9 blood draws by IV catheter. Participants will drink sugar water. - Sitting test - Activity monitored - Meal (food buffet)

NCT ID: NCT03215173 Completed - Diabetes Clinical Trials

Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease

FAB
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study plans to learn more about how to increase postpartum weight loss and how to decrease risk factors for postpartum women at increased risk for diabetes and heart disease. The program is delivered using a mobile application (app) and a lifestyle coach. This mobile application is developed for women who are at higher risk for diabetes and heart disease. Women who have gestational diabetes, (diabetes during pregnancy, or GDM), gestational hypertension (high blood pressure), and/or preeclampsia (high blood pressure and protein in the urine), and/or small-for gestational-age, and/or preterm (early) delivery during their pregnancies have a higher risk for diabetes and heart disease. This mobile application was developed using the latest research studies and using the evidence-based Diabetes Prevention and Colorado Weigh programs. The goal of the program is to help women lose weight and participate in physical activity after delivery.

NCT ID: NCT03208010 Completed - Clinical trials for Overweight and Obesity

Diabetes Prevention for Mexican Americans

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study tests a culturally tailored lifestyle intervention designed to prevent, or delay onset of, T2DM in Mexican Americans with prediabetes. Half the participants take part in a lifestyle program that emphasizes preparing and eating healthy Mexican American foods and increasing physical activity; the other half take part in an "enhanced" usual care control group.

NCT ID: NCT03202043 Completed - Overweight Clinical Trials

The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake

Start date: April 6, 2018
Phase: N/A
Study type: Interventional

This study is designed to see if drinking a tomato-based vegetable juice will increase skin carotenoids.

NCT ID: NCT03198793 Completed - Hypertension Clinical Trials

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins

NEW-HOPE
Start date: October 13, 2017
Phase: Phase 2
Study type: Interventional

Essential hypertension (HTN) is a disease that affects approximately 1 billion individuals worldwide. Despite the availability of effective and safe anti-hypertensive drugs, 65% of subjects diagnosed with HTN do not have their blood pressure (BP) controlled (<140/90 mmHg). The overall incidence of resistant HTN, (defined as requiring 3 or more anti-hypertensive drugs, including a diuretic, to control BP) is estimated to be 15% of the hypertensive population. Consequently, there is a pressing unmet medical need to develop new classes of anti-hypertensive drugs that act on alternative pathways and further control BP and the associated cardiovascular risks in subjects. The prevalence of HTN in African Americans in the United States is among the highest in the world, and HTN is more common in African Americans than in Caucasians. One of the risk factors for HTN is sodium sensitivity. There is a higher association of HTN with sodium sensitivity in African American subjects and other racial/ethnic groups who are overweight/obese. Effective agents to treat HTN in this high-risk population are clearly needed. This study will be conducted in a hypertensive, overweight subject population of multiple ethnic origins in which QGC001 is likely, based on its mode of action, to demonstrate a significant anti-hypertensive effect.

NCT ID: NCT03192254 Completed - Clinical trials for Overweight and Obesity

Understanding Mechanisms of Health Behavior Change

Start date: July 13, 2017
Phase: N/A
Study type: Interventional

This research seeks to examine psychological factors that may impact relationship between incentives and health behavior engagement, specifically fruit and vegetable consumption. Additionally, it will compare the impact of two different incentive schedules on behavior engagement, one providing immediate rewards (i.e. rewards received on a daily basis) and another providing delayed rewards (i.e. rewards received at the end of the study period), with a control condition in which no rewards are offered. Study participants will provide reports of their fruit and vegetable consumption each day for three weeks, and in the two incentive conditions, they will receive small monetary rewards for their fruit and vegetable consumption. Following the three week reporting and reward period, participants will complete two additional assessments, measuring psychological constructs and behavior engagement following the cessation of rewards. The study will also examine how cognitive and anthropomorphic factors may contribute to intervention response and the effects on psychological constructs.

NCT ID: NCT03191591 Completed - Physical Activity Clinical Trials

The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life

Start date: August 9, 2016
Phase: N/A
Study type: Interventional

The First 1000 Days (conception to age 2) is a crucial period for the development and prevention of obesity and its adverse consequences in mother-child pairs and their families. The overall aim of the First 1000 Days program is to work across early-life systems to prevent obesity, promote healthy routines and behaviors, address social determinants of health, and reduce health disparities among vulnerable children and families at community health centers in the Boston, MA area. The study aims to simultaneously implement and evaluate an obesity prevention program across early life systems to reduce the prevalence of obesity risk factors within racial/ethnic minority families, close the gap in maternal-child health disparities, and assess and address social determinants of health.